SCHEMBL7712449

SCHEMBL7712449

CN1CCN(c2nc(N)ncc2Cc2ccc(Cl)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.56
HRH4 Q9H3N8 10/20 0.55
HRH3 Q9Y5N1 2/20 0.44
KCNH2 Q12809 1/20 0.44
DHFR P00374 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714119 0.91 HRH4 (0.53) HTR6HRH4DHFR
SCHEMBL7716650 0.89 HRH4 (0.53) HTR6HRH4HRH3KCNH2
SCHEMBL7714282 0.89 HRH4 (0.56) HTR6HRH4HRH3KCNH2DHFR
SCHEMBL7708437 0.88 KDM4E (0.44) HTR6HRH4DHFR
SCHEMBL7713555 0.88 HRH4 (0.52) HTR6HRH4HRH3KCNH2
SCHEMBL8124120 0.88 HTR6 (0.45) HTR6HRH4HRH3
SCHEMBL7708547 0.88 HTR6 (0.56) HTR6HRH4HRH3KCNH2DHFR
SCHEMBL7708456 0.88 HRH4 (0.55) HTR6HRH4HRH3KCNH2
SCHEMBL7714603 0.87 HRH4 (0.57) HTR6HRH4HRH3KCNH2
SCHEMBL7714413 0.86 ROCK2 (0.44) HTR6HRH4DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed